Clinical Oncology
Volume 24, Issue 1 , Pages 30-38 , February 2012

Testing Testes: Problems and Recent Advances in the Diagnosis of Testicular Tumours and Implications for Treatment

  • S.S. Jeetle
  • ,
  • D.M. Berney

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: D.M. Berney, Department of Molecular Oncology, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK. Tel: +44-207-882-3551.

Received 3 May 2011 ,Revised 14 June 2011 ,Accepted 5 July 2011.

References 

  1. Collins DH, Pugh RC. Classification and frequency of testicular tumours. Br J Urol. 1964;36(Suppl.):1–11
  2. Berney DM. Staging and classification of testicular tumours: pitfalls from macroscopy to diagnosis. J Clin Pathol. 2008;61:20–24
  3. Rajab R, Berney DM. Ten testicular trapdoors. Histopathology. 2008;53:728–739
  4. World Health Organization. Classification of tumours. Pathology and genetics of tumours of the urinary system. Lyon: IARC Press; 2004;
  5. Freedman LS, Parkinson MC, Jones WG, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987;2:294–298
  6. Sesterhenn IA, Weiss RB, Mostofi FK, et al. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol. 1992;10:69–78
  7. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18(Suppl. 2):S61–S79
  8. Ulbright TM, Loehrer PJ, Roth LM, et al. The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer. 1984;54:1824–1833
  9. Ahmed T, Bosl GJ, Hajdu SI. Teratoma with malignant transformation in germ cell tumors in men. Cancer. 1985;56:860–863
  10. Ulbright TM, Srigley JR. Dermoid cyst of the testis: a study of five postpubertal cases, including a pilomatrixoma-like variant, with evidence supporting its separate classification from mature testicular teratoma. Am J Surg Pathol. 2001;25:788–793
  11. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed.. New York: Wiley-Liss; 2002;
  12. Warde P, Specht L, Horwich A, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20:4448–4452
  13. Krag Jacobsen G, Barlebo H, Olsen J, et al. Testicular germ cell tumours in Denmark 1976–1980. Pathology of 1058 consecutive cases. Acta Radiol Oncol. 1984;23:239–247
  14. Grossfeld GD, Small EJ. Long-term side effects of treatment for testis cancer. Urol Clin North Am. 1998;25:503–515
  15. Lee AH, Theaker JM. Pagetoid spread into the rete testis by testicular tumours. Histopathology. 1994;24:385–389
  16. Due W, Loy V. Evidence of interepithelial seminoma spread into the rete testis by immunostaining of paraffin sections with antibodies against cytokeratin and vimentin. Urol Res. 1988;16:389–393
  17. Browne TJ, Richie JP, Gilligan TD, et al. Intertubular growth in pure seminomas: associations with poor prognostic parameters. Hum Pathol. 2005;36:640–645
  18. Tokuc R, Sakr W, Pontes JE, et al. Accuracy of frozen section examination of testicular tumors. Urology. 1992;40:512–516
  19. Elert A, Olbert P, Hegele A, et al. Accuracy of frozen section examination of testicular tumors of uncertain origin. Eur Urol. 2002;41:290–293
  20. Leroy X, Rigot JM, Aubert S, et al. Value of frozen section examination for the management of nonpalpable incidental testicular tumors. Eur Urol. 2003;44:458–460
  21. Winstanley AM, Mikuz G, Debruyne F, et al. Handling and reporting of biopsy and surgical specimens of testicular cancer. Eur Urol. 2004;45:564–573
  22. Connolly SS, D’Arcy FT, Bredin HC, et al. Value of frozen section analysis with suspected testicular malignancy. Urology. 2006;67:162–165
  23. Young RH. Testicular tumors – some new and a few perennial problems. Arch Pathol Lab Med. 2008;132:548–564
  24. Ulbright TM, Young RH. Seminoma with conspicuous signet ring cells: a rare, previously uncharacterized morphologic variant. Am J Surg Pathol. 2008;32:1175–1181
  25. Ulbright TM, Young RH. Seminoma with tubular, microcystic, and related patterns: a study of 28 cases of unusual morphologic variants that often cause confusion with yolk sac tumor. Am J Surg Pathol. 2005;29:500–505
  26. Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lancet. 1972;2:516–517
  27. Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer. 1999;83:815–822
  28. Loy V, Dieckmann KP. Carcinoma in situ of the testis: intratubular germ cell neoplasia or testicular intraepithelial neoplasia?. Hum Pathol. 1990;21:457–458
  29. Skakkebaek NE, Berthelsen JG, Giwercman A, et al. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987;10:19–28
  30. Sonne SB, Kristensen DM, Novotny GW, et al. Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Int J Androl. 2008;31:275–287
  31. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16:972–978
  32. Masson P. Etude sur le seminome. Rev Can Biol. 1946;5:361–387
  33. True LD, Otis CN, Delprado W, et al. Spermatocytic seminoma of testis with sarcomatous transformation. A report of five cases. Am J Surg Pathol. 1988;12:75–82
  34. Looijenga LH, Oosterhuis JW. Pathogenesis of testicular germ cell tumours. Rev Reprod. 1999;4:90–100
  35. Stoop H, van Gurp R, de Krijger R, et al. Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest. 2001;81:919–928
  36. Simmonds PD, Lee AH, Theaker JM, et al. Primary pure teratoma of the testis. J Urol. 1996;155:939–942
  37. Dieckmann KP, Loy V. Epidermoid cyst of the testis: a review of clinical and histogenetic considerations. Br J Urol. 1994;73:436–441
  38. Manivel JC, Reinberg Y, Niehans GA, et al. Intratubular germ cell neoplasia in testicular teratomas and epidermoid cysts. Correlation with prognosis and possible biologic significance. Cancer. 1989;64:715–720
  39. Surti U, Hoffner L, Chakravarti A, et al. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. Am J Hum Genet. 1990;47:635–643
  40. Looijenga LH, Oosterhuis JW, Ramaekers FC, et al. Dual parameter flow cytometry for deoxyribonucleic acid and intermediate filament proteins of residual mature teratoma. All tumor cells are aneuploid. Lab Invest. 1991;64:113–117
  41. Schmoll HJ, Souchon R, Krege S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol. 2004;15:1377–1399
  42. Michael H, Lucia J, Foster RS, et al. The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol. 2000;24:257–273
  43. Ulbright TM, Henley JD, Cummings OW, et al. Cystic trophoblastic tumor: a nonaggressive lesion in postchemotherapy resections of patients with testicular germ cell tumors. Am J Surg Pathol. 2004;28:1212–1216
  44. Comiter CV, Kibel AS, Richie JP, et al. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol. 1998;159:859–863
  45. Clevenger JA, Foster RS, Ulbright TM. Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma. Mod Pathol. 2009;22:1361–1366
  46. Michael H, Hull MT, Ulbright TM, et al. Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol. 1997;21:896–904
  47. Motzer RJ, Amsterdam A, Prieto V, et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol. 1998;159:133–138
  48. Necchi A, Colecchia M, Nicolai N, et al. Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal. BJU Int. 2010;107:1088–1094
  49. Spiess PE, Pisters LL, Liu P, et al. Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol. 2008;26:595–599
  50. Oosterhuis JW, Suurmeyer AJ, Sleyfer DT, et al. Effects of multiple-drug chemotherapy (cis-diammine-dichloroplatinum, bleomycin, and vinblastine) on the maturation of retroperitoneal lymph node metastases of nonseminomatous germ cell tumors of the testis. No evidence for de novo induction of differentiation. Cancer. 1983;51:408–416
  51. Colecchia M, Necchi A, Paolini B, et al. Teratoma with somatic-type malignant components in germ cell tumors of the testis: a clinicopathologic analysis of 40 cases with outcome correlation. Int J Surg Pathol. 2011;19:321–327
  52. Ulbright TM, Berney DM. Testicular and paratesticular tumors. In:  Mills SE editors. Sternberg’s diagnostic surgical pathology. Philadelphia: Lippincott, Williams and Wilkins; 2009;
  53. Proppe KH, Scully RE. Large-cell calcifying Sertoli cell tumor of the testis. Am J Clin Pathol. 1980;74:607–619
  54. Dreyer L, Jacyk WK, du Plessis DJ. Bilateral large-cell calcifying Sertoli cell tumor of the testes with Peutz-Jeghers syndrome: a case report. Pediatr Dermatol. 1994;11:335–337
  55. Niewenhuis JC, Wolf MC, Kass EJ. Bilateral asynchronous Sertoli cell tumor in a boy with the Peutz-Jeghers syndrome. J Urol. 1994;152:1246–1248
  56. Jayasena SN, Ariyasinghe JT, Gunawardena DM, et al. Large-cell calcifying Sertoli cell tumour of the testis detected at screening of a family with Carney syndrome. Urol Int. 2005;75:365–367
  57. Noszian IM, Balon R, Eitelberger FG, et al. Bilateral testicular large-cell calcifying Sertoli cell tumor and recurrent cardiac myxoma in a patient with Carney’s complex. Pediatr Radiol. 1995;25(Suppl. 1):S236–S237
  58. Washecka R, Dresner MI, Honda SA. Testicular tumors in Carney’s complex. J Urol. 2002;167:1299–1302
  59. Petersson F, Bulimbasic S, Sima R, et al. Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene. Hum Pathol. 2010;41:552–559
  60. Scully RE. Gonadoblastoma. A review of 74 cases. Cancer. 1970;25:1340–1356
  61. Tsuchiya K, Reijo R, Page DC, et al. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet. 1995;57:1400–1407
  62. Lau YF, Li Y, Kido T. Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res C Embryo Today. 2009;87:114–122
  63. Schnieders F, Dork T, Arnemann J, et al. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet. 1996;5:1801–1807
  64. Lau YF. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet. 1999;64:921–927
  65. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244–2250
  66. Jones TD, Ulbright TM, Eble JN, et al. OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res. 2004;10:8544–8547
  67. Jones TD, Ulbright TM, Eble JN, et al. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol. 2004;28:935–940
  68. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379–391
  69. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells. 2001;19:271–278

PII: S0936-6555(11)00791-6

doi: 10.1016/j.clon.2011.08.005

Clinical Oncology
Volume 24, Issue 1 , Pages 30-38 , February 2012